Loading…
avatar for Susan Rosencrance

Susan Rosencrance

FDA
Director, Office of Lifecycle Drug Products, OPQ, CDER
Dr. Susan Rosencrance presently heads FDA's Office of Lifecycle Drug Products within the Office of Pharmaceutical Quality (OPQ). She provides executive leadership by overseeing and directing scientific review programs and activities related to evaluating drug product quality throughout the lifecycle (brand to generic). Susan has a long history with the FDA working in various roles within CDER. Prior to joining the Agency she worked at Merck's R&D labs in a new drug discovery program. She holds a Ph.D. in Chemistry from American University and completed her dissertation research in the Laboratory of Biophysical Chemistry at the National Institutes of Health (NIH).

My Speakers Sessions

Monday, June 25
 

11:00am

 
Tuesday, June 26
 

10:30am